Sarcoidosis in untreated chronic hepatitis C virus infection

References

• Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149–73.
   Google Scholar
• du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med 2003;253:4–17.
   PubMed Web of Science ®Google Scholar
• Leclere S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med 2003;14:237–43.
   PubMedGoogle Scholar
• Tahan V, Ozseker F, Guneylioglu D, Baran A, Ozaras R, Mert A, et al. Sarcoidosis after use of interferon for chronic hepatitis C:report of a case and review of the literature. Dig Dis Sci 2003;48:169–73.
   PubMed Web of Science ®Google Scholar
• Nawras A, Alsolaiman MM, Mehboob S, Bartholomew C, Maliakkal B. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci 2002;47:1627–31.
   Google Scholar
• Hoffmann RM, Jung MC, Motz R, Gossl C, Emslander HP, Zachoval R, et al. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. J Hepatol 1998;28:1058–63.
   PubMed Web of Science ®Google Scholar
• Gitlin N. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. Eur J Gastroenterol Hepatol 2002;14:883–5.
   PubMed Web of Science ®Google Scholar
• Cogrel O, Doutre MS, Marliere V, Beylot-Barry M, Couzigou P, Beylot C. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. Br J Dermatol 2002;146:320–4.
   Google Scholar
• Perez-Alvarez R, Perez-Lopez R, Lombrana JL, Rodriguez M, Rodrigo L. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. J Viral Hepat 2002;9:75–9.
   PubMed Web of Science ®Google Scholar
• Li SD, Yong S, Srinivas D, Van Thiel DH. Reactivation of sarcoidosis during interferon therapy. J Gastroenterol 2002;37:50–4.
   Google Scholar
• Nakajima M, Kubota Y, Miyashita N, Niki Y, Matsushima T, Manabe T. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C. Intern Med 1996;35:376–9.
   PubMedGoogle Scholar
• Teragawa H, Hondo T, Takahashi K, Watanabe H, Ohe H, Hattori N, et al. Sarcoidosis after interferon therapy for chronic active hepatitis C. Intern Med 1996;35:19–23.
   PubMed Web of Science ®Google Scholar
• Bonnet F, Morlat P, Dubuc J, De Witte S, Bonarek M, Bernard N, et al. Sarcoidosis-associated hepatitis C virus infection. Dig Dis Sci 2002;47:794–6.
   Google Scholar
• Baz K, Yazici AC, Kaya TI, Ikizoglu G, Ulubas B, Apa DD, et al. Neutrophilic dermatosis of the hands (localized Sweet’s syndrome) in association with chronic hepatitis C and sarcoidosis. Clin Exp Dermatol. 2003;28:377–9.
   PubMedGoogle Scholar
• Cossu A, Cossu PA, Carcassi A. Chronic polyarthritis in a patient affected by sarcoidosis and chronic HCV infection. Case report and review of the literature. Reumatism 2002;54:144–9.
   Google Scholar
• Yamada S, Mine S, Fujisaki T, Ohnari N, Eto S, Tanaka Y. Hepatic sarcoidosis associated with chronic hepatitis C. J Gastroenterol. 2002;37:564–70.
   PubMed Web of Science ®Google Scholar
• Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:24–31.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003;361:1111–8.
   PubMed Web of Science ®Google Scholar
• Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999;30:595–601.
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002;36:S21–9.
   PubMed Web of Science ®Google Scholar
• Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 2003;37:1189–98.
   PubMed Web of Science ®Google Scholar
• Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996;24: 759–65.
   Google Scholar
• Bertoletti A, D’Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, et al. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997;112:193–9.
   PubMedGoogle Scholar
• Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 1987;59:896–900.
   PubMedGoogle Scholar
• Bobbio-Pallavicini E, Valsecchi C, Tacconi F, Moroni M, Porta C. Sarcoidosis following beta-interferon therapy for multiple myeloma. Sarcoidosis 1995;12:140–2.
   Google Scholar
• Pietropaoli A, Modrak J, Utell M. Interferon-alpha therapy associated with the development of sarcoidosis. Chest 1999; 116:569–72.
   Google Scholar
• Luers C, Sudhop T, Spengler U, Berthold HK. Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection. J Hepatol 1999;30:347.
   PubMedGoogle Scholar
• Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci 2003;325:135–48.
   PubMed Web of Science ®Google Scholar